NCT05950594RecruitingPhase 2
IVIM & OLINK in Sarcoma
Prospective Study of Image and Blood-derived Biomarkers to Predict Metastasis in Soft-tissue Sarcomas
Source: ClinicalTrials.gov · Last updated 16 Mar 2026
Brief summary (registry, in English)
The hypoxia \> metastasis axis suggests that a DWI-based biomarker of hypoxia incorporating IVIM may be able to predict metastasis in STS patients, ultimately enabling stratification for personalized treatments at the time of diagnostic (MR) imaging, without adding an excessive burden to the patient or clinical workflow (typical DWI/IVIM sequences can be acquired acquired in approximately 5 minutes).
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 145 (estimated)
- First submitted
- 10 Jul 2023
- Start date
- 5 Mar 2024
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- University Health Network, Toronto
- Diseases
- Sarcoma
- NCT number
- NCT05950594
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 145
- From 5 Mar 2024 to the primary completion date, 30 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Contraindication to MRI scan as per current institutional guidelines (for patients requiring MRI)
Who the study is looking for
- Age ≥ 18 years
- Ability to understand and the willingness to sign a written informed consent document
- Grade 2 or 3 soft tissue sarcoma greater than 5 cm in largest dimension
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Health Network Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.